Werner Gladdines Email

VP, Program Management & Clinical Development Operations . Immunic Therapeutics

Current Roles

Employees:
88
Revenue:
$13.6M
About
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn's disease, and psoriasis.
Immunic Therapeutics Address
1200 Avenue of the Americas
New York City, NY
United States
Immunic Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.